Drug Information Association Logo
« Back to Listing

Risk Sharing or Risk Transfer? Striking the Perfect Balance in Strategic Partnerships

Track:
Innovative Partnering Models and Outsourcing Strategies

Day & Time:
June 16, 11:00AM - 12:30PM (Pacific Standard Time)

Session Number:
127

Room Number:
3

Level:
Intermediate

Type:
Forum

Title:
Risk Sharing or Risk Transfer? Striking the Perfect Balance in Strategic Partnerships

Chair(s):
Andrew Townshend
Vice President, Alliance Development
INC Research, United States

Description:
Sponsors continue to pursue partnerships that transfer accountability to their CRO partners based on performance, while CROs seek a better balance between risk and reward. This forum explores risk-sharing arrangements, related benefits, and drawbacks.

Learning Objective(s):
Assess when it makes sense to evolve beyond a tactical relationship; Evaluate the benefits and drawbacks of different risk-sharing arrangements; Apply strategies to ensure more successful partnerships.

Presentation(s) & Speaker(s):
Panelist
Mark L. Lacy
President and Chief Executive Officer
Benchmark Research, United States

Panelist
Mark A. Sanders, MBA
Senior Director, Clinical Development and Medical Sourcing Lead
Pfizer Inc, United States

Panelist
Linda G Strause, PhD
Principal and Founder
Strategic Clinical Consultants, United States